Clinical Trial Update: Methylphenidate for Cancer-Related Fatigue [Phase 1]

View source ↗

Summary

Phase 1 trial of methylphenidate for cancer-related fatigue was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Cancer | Phase 1 | Status: TERMINATED | Results posted: 2019-04-26